CN110934908A - Compound nutritional health product capable of increasing body temperature to prevent diseases - Google Patents
Compound nutritional health product capable of increasing body temperature to prevent diseases Download PDFInfo
- Publication number
- CN110934908A CN110934908A CN201811108787.8A CN201811108787A CN110934908A CN 110934908 A CN110934908 A CN 110934908A CN 201811108787 A CN201811108787 A CN 201811108787A CN 110934908 A CN110934908 A CN 110934908A
- Authority
- CN
- China
- Prior art keywords
- compound
- body temperature
- ginsenoside
- glycyrrhizic acid
- nutraceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 60
- 150000001875 compounds Chemical class 0.000 title claims abstract description 59
- 230000036760 body temperature Effects 0.000 title claims abstract description 58
- 230000036541 health Effects 0.000 title claims abstract description 49
- 201000010099 disease Diseases 0.000 title claims abstract description 35
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 35
- 230000001965 increasing effect Effects 0.000 title description 13
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 38
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 21
- 235000006545 Ziziphus mauritiana Nutrition 0.000 claims abstract description 17
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims abstract description 17
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 16
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 29
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 29
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 29
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 29
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 29
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 29
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 28
- 235000013305 food Nutrition 0.000 claims description 28
- 239000002994 raw material Substances 0.000 claims description 17
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 claims description 16
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims description 14
- 229960003720 enoxolone Drugs 0.000 claims description 14
- 229940089161 ginsenoside Drugs 0.000 claims description 14
- 229930182494 ginsenoside Natural products 0.000 claims description 14
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 claims description 12
- 239000002417 nutraceutical Substances 0.000 claims description 12
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 12
- 230000036039 immunity Effects 0.000 claims description 11
- 239000000843 powder Substances 0.000 claims description 11
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 claims description 10
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 claims description 10
- 230000004060 metabolic process Effects 0.000 claims description 10
- 239000002775 capsule Substances 0.000 claims description 9
- 229940069445 licorice extract Drugs 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims description 8
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 claims description 7
- 239000000654 additive Substances 0.000 claims description 7
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 claims description 7
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 claims description 7
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 claims description 6
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 claims description 6
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 claims description 6
- 239000002552 dosage form Substances 0.000 claims description 6
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 claims description 6
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 claims description 6
- 235000013402 health food Nutrition 0.000 claims description 6
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 5
- 239000003937 drug carrier Substances 0.000 claims description 4
- 239000000839 emulsion Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000007937 lozenge Substances 0.000 claims description 4
- 239000003094 microcapsule Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 3
- 239000006186 oral dosage form Substances 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims 6
- 239000000047 product Substances 0.000 claims 6
- 235000005911 diet Nutrition 0.000 claims 2
- 230000000378 dietary effect Effects 0.000 claims 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 229940127557 pharmaceutical product Drugs 0.000 claims 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 claims 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 9
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 9
- 235000011477 liquorice Nutrition 0.000 abstract description 9
- 239000003814 drug Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 230000002411 adverse Effects 0.000 description 12
- 241001247821 Ziziphus Species 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 9
- 230000035764 nutrition Effects 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000012545 processing Methods 0.000 description 7
- 230000007774 longterm Effects 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 2
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 230000001078 anti-cholinergic effect Effects 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 239000002899 monoamine oxidase inhibitor Substances 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- 230000035924 thermogenesis Effects 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000748489 Smallanthus Species 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229960003920 cocaine Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229940005483 opioid analgesics Drugs 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001331 thermoregulatory effect Effects 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- -1 troches Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a compound nutritional health product capable of raising body temperature to prevent diseases, which comprises ginseng extract, liquorice extract and Chinese date extract as main components.
Description
Technical Field
The invention relates to a compound nutritional health product capable of raising body temperature to prevent diseases, in particular to a compound nutritional health product capable of raising body temperature to prevent diseases, which is prepared from ginseng extract, liquorice extract and Chinese date extract.
Background
Body temperature is an important vital sign of human beings, and modern medical research shows that body temperature is in direct proportion to metabolism, the basal metabolic rate is increased by about 13% when the body temperature is increased by 1 ℃, a plurality of researches show that the body temperature is increased to greatly enhance immunity, and human beings and animals usually adopt a body temperature raising mode to resist a plurality of diseases, and the traditional Chinese medicine also considers that body cold is a source of ten thousands of diseases. In recent years, many books written by doctors of the primary knot of doctor of Japanese medicine doctor indicate that the increase in body temperature can greatly enhance immunity and can prevent and treat many diseases. In 9 months of 2008, a clinic is opened in the fifth major lane of manhattan in new york, and a medical doctor of manhattan famous medical science zitazechu who deeply intersects famous people such as pilgritz, clinton, beckhem, a-Rod, and smallanthus, also indicates in his written book that the body temperature is reduced by 1 ℃, the immunity is reduced by 30%, the hypothermia can also cause acidification in vivo, accelerate aging, and deteriorate healthy cell metabolism. Therefore, the health care product which can increase the body temperature and has no adverse side effect can be taken by people for a long time to maintain the health and prevent and resist diseases.
In the prior art, thyroid hormone (thyroidodhormone) for promoting metabolism can increase thermogenesis to raise body temperature, but if excessive or dosage is increased too fast, adverse side effects such as palpitation, pulse pressure rise, arrhythmia, angina and even heartbeat stop can be caused, and Theophylline (Theophylline) for treating bronchial diseases can also increase thermogenesis to raise body temperature, but adverse side effects such as headache, nausea, insomnia, palpitation and the like can be caused. Some drugs affect the physiological mechanism of central system for regulating heat to raise body temperature, such as monoamine oxidase inhibitor (MAO-I) and Opioids, which may affect the mechanism of body temperature regulation by increasing heat generation to cause fever, and other anticholinergic drugs, tricyclic antidepressants, antihistamines and synthetic alkaloids (such as cocaine) may affect hypothalamic thermoregulatory center and lower peripheral blood temperature, resulting in the symptoms of fever with anticholinergic toxicity. Because the above-mentioned drugs for increasing body temperature in the prior art have many disadvantages of adverse side effects, they are not suitable for human to take for a long time to increase body temperature to maintain health and prevent diseases. Therefore, the invention discloses a health care product which can increase body temperature and has no adverse side effect after long-term use, so that people can maintain health and prevent and resist diseases, and the defects in the prior art can be solved.
Therefore, the inventor is careful to research and explore, and has a mind that is not bound by the inventor to solve the deficiency of the prior art, and finally conceive the 'compound nutritional health care product capable of raising the body temperature to prevent diseases'.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention aims to provide a compound nutritional health-care product which is prepared by taking a ginseng extract, a liquorice extract and a Chinese date extract as raw materials and can raise the body temperature to prevent diseases, in particular to a novel technical scheme which can not only increase the body temperature after being taken, but also has no adverse side effect after being taken for a long time and can be taken by people for a long time to maintain health and prevent and resist diseases.
The invention relates to a solution of a compound nutritious health product for raising body temperature to prevent diseases, which is the result of intensive research and research by the inventor and experiments by adopting examples, because the medicines capable of raising body temperature in the prior art have a plurality of defects of adverse side effects and are not suitable for long-term taking of human beings for raising body temperature to maintain health and prevent diseases, the inventor adopts the components in the plants such as ginseng, liquorice, Chinese date and the like which are eaten by human beings daily since ancient times as raw materials to prepare the compound nutritious health product which can not only raise body temperature but also has no adverse side effects after long-term taking, and can be taken by human beings for long term to maintain health and prevent and resist diseases.
The compound nutritional health product comprises the following raw materials: ginseng extract, licorice extract and jujube extract, and the index components of each extract include ginsenoside Rg1 and Rb1, glycyrrhizic acid and glycyrrhetinic acid, and jujube cyclic adenosine monophosphate.
Because the ginsenoside Re can be metabolized into the ginsenoside Rg1 in a human body, the ginsenoside Re can be used for replacing the ginsenoside Rg1 when the compound nutritional health-care product is prepared, and the ginsenoside Rd can be metabolized into the ginsenoside Rb1 in the human body, so the ginsenoside Rd can be used for replacing the ginsenoside Rb1 when the compound nutritional health-care product is prepared. After taking the embodiment of the invention, many people can not only raise the body temperature, but also can not catch a cold for a long time, and has no adverse side effect.
The technology disclosed by the invention can be applied to prepare special medical food, health-care food, nutrition auxiliary food and medicines which are suitable for human beings to take for a long time to raise the body temperature so as to promote metabolism and enhance immunity, has the advantage of high safety after long-term taking, and further overcomes the defects of a plurality of adverse side effects in the prior art.
The invention discloses a compound nutritional health product capable of raising body temperature to prevent diseases, which comprises the following raw materials: ginseng extract, licorice extract and jujube extract.
Preferably, the index components of the raw materials of the compound nutritional health product comprise: the ginseng extract comprises 2-27 parts by weight of ginsenoside (Rg1+ Rb 1); and the licorice extract contains 3-49 parts by weight of glycyrrhizic acid, and the glycyrrhizic acid is selected from one of glycyrrhizic acid, glycyrrhetinic acid and a combination thereof; and the jujube extract contains 0.002-0.6 weight part of jujube cyclic adenosine monophosphate.
Preferably, the compound nutritional health product comprises one selected from food nutrition and pharmaceutically acceptable carriers, additives and combinations thereof.
Preferably, the compound nutritional health product is prepared into a dosage form, and the dosage form is one of lozenge, capsule, powder, tablet, powder, solution, microcapsule, suspension, emulsion, granule, dripping pill, pill and pharmaceutical oral dosage forms.
Preferably, the compound nutritional health product comprises special medical food, health food, nutritional auxiliary food and medicines which can be prepared into special medical food, health food, nutritional auxiliary food and medicines for raising body temperature to promote metabolism and enhance immunity.
According to another aspect of the present invention, there is disclosed a compound nutraceutical for increasing body temperature to prevent diseases, comprising: a first main component comprising 2-27 parts by weight of ginsenoside (Rg1+ Rb 1); and a second main component comprising 3 to 49 parts by weight of a glycyrrhizic acid selected from the group consisting of glycyrrhizic acid, glycyrrhetinic acid, and combinations thereof; and the third main component, which contains 0.002-0.6 weight part of jujube cyclic adenosine monophosphate.
Preferably, the compound nutritional health product of the invention comprises one selected from a food nutrition and pharmaceutically acceptable carrier, an additive and a combination thereof.
Preferably, the compound nutritional health product comprises a preparation form, wherein the preparation form is one selected from lozenge, capsule, powder, tablet, powder, solution, microcapsule, suspension, emulsion, granule, dripping pill, pill and pharmaceutical oral preparation forms.
Preferably, the compound nutritional health product comprises special medical food, health food, nutritional auxiliary food and medicines which can be prepared into special medical food, health food, nutritional auxiliary food and medicines for raising body temperature to promote metabolism and enhance immunity.
According to another aspect of the present invention, a compound nutraceutical for elevating body temperature to prevent diseases, comprises: a first main component comprising a first ginsenoside (selected from ginsenoside Rg1, ginsenoside Re, and combinations thereof) and a second ginsenoside (selected from ginsenoside Rb1, ginsenoside Rd, and combinations thereof); and a second main component comprising glycyrrhizic acid (selected from glycyrrhizic acid, glycyrrhetinic acid, and combinations thereof); and the third main component is prepared with date cyclic adenosine monophosphate.
After the present invention is disclosed, the ordinary addition and subtraction cutting of the nutrition health care product by the technicians in the field is all the ordinary technical activities of the technicians in the field, so the compound nutrition health care product capable of raising the body temperature to prevent the diseases is the core content for realizing the purpose of the present invention, and the compound nutrition health care product is all within the protection scope of the present invention.
In order to make the invention more comprehensible, the following detailed description is given with reference to the accompanying drawings.
Drawings
FIG. 1 is a schematic flow chart of a method for preparing a nutraceutical according to an embodiment of the present invention.
Fig. 2 is a schematic flow chart of a method for preparing the five-component nutritional health product of the invention.
Detailed Description
The invention will be further explained with reference to the drawings and examples. The compound nutritional health-care product is prepared by combining the characteristics of the invention by adopting a method known by persons skilled in the art. The following examples are for illustrative purposes only and are not intended to limit the present invention.
In order to achieve the purpose of the invention, the invention particularly proposes the following technical solutions.
The invention discloses a compound nutritional health product capable of raising body temperature to prevent diseases, which is prepared from raw materials including ginseng extract, licorice extract, Chinese date extract and the like.
The first scheme is as follows:
the compound nutritional health product capable of raising body temperature to prevent diseases is prepared by processing raw materials containing ginseng extract, liquorice extract and Chinese date extract.
Scheme II:
the compound nutritional health product is prepared by processing raw materials of ginseng extract containing 2-27 parts by weight of ginsenoside (Rg1+ Rb1), liquorice extract containing 3-49 parts by weight of glycyrrhizic acid (one of glycyrrhizic acid, glycyrrhetinic acid and a combination thereof), and Chinese date extract containing 0.002-0.6 part by weight of Chinese date cyclic adenosine monophosphate.
The third scheme is as follows:
the compound nutritional health product of the invention can contain carriers or additives acceptable in food nutrition and pharmacy, and can be prepared into any pharmaceutically known oral pharmaceutical dosage forms such as troches, capsules, powder and the like.
And the scheme is as follows:
the nutrient health-care product of the invention can be prepared into special medical food, health-care food, nutrient auxiliary food and medicines which can raise body temperature to promote metabolism and enhance immunity.
And a fifth scheme:
the compound nutrient health-care product capable of raising body temperature and preventing diseases is prepared by processing raw materials of a first main component containing 2-27 parts by weight of ginsenoside (Rg1+ Rb1), a second main component containing 3-49 parts by weight of glycyrrhizic acid (one selected from glycyrrhizic acid, glycyrrhetinic acid and a combination thereof), and a third main component containing 0.002-0.6 part by weight of jujube cyclic adenosine monophosphate.
Scheme six:
the compound nutrient health-care product capable of raising body temperature and preventing diseases is prepared by processing raw materials of a first main component containing first ginsenoside (selected from ginsenoside Rg1, ginsenoside Re and one of the combination thereof) and second ginsenoside (selected from ginsenoside Rb1, ginsenoside Rd and one of the combination thereof), a second main component containing glycyrrhizic acid (selected from glycyrrhizic acid, glycyrrhetinic acid and one of the combination thereof) and a third main component containing jujube cyclic adenosine monophosphate.
In order to achieve the purpose of the invention, the preparation method of the compound nutritional health product is particularly provided.
The method comprises the following steps:
the raw materials containing ginseng extract, licorice extract and Chinese date extract are processed into the compound nutritional health-care product capable of raising body temperature to prevent diseases.
The second method comprises the following steps:
processing raw materials of a ginseng extract containing 2-27 parts by weight of ginsenoside (Rg1+ Rb1), a liquorice extract containing 3-49 parts by weight of glycyrrhizic acid (selected from glycyrrhizic acid, glycyrrhetinic acid and one of the combination thereof), and a Chinese date extract containing 0.002-0.6 part by weight of Chinese date cyclic adenosine monophosphate to prepare the compound nutritional health product.
The third method comprises the following steps:
the compound nutritional health product of the invention is added with carriers or additives which contain food nutrition and are acceptable in pharmacy to be prepared into any pharmaceutical dosage forms known in pharmacy, such as troches, capsules, powder and the like.
The method four comprises the following steps:
the nutritional health-care product of the invention is prepared into special medical food, health-care food, nutritional auxiliary food and medicine which can increase the body temperature to promote metabolism and enhance immunity.
The method five comprises the following steps:
the compound nutritional health product capable of raising body temperature and preventing diseases is prepared by processing raw materials of a first main component containing 2-27 parts by weight of ginsenoside (Rg1+ Rb1), a second main component containing 3-49 parts by weight of glycyrrhizic acid (one selected from glycyrrhizic acid, glycyrrhetinic acid and a combination thereof), and a third main component containing 0.002-0.6 part by weight of jujube cyclic adenosine monophosphate.
The method six:
the compound nutrient health-care product capable of raising body temperature and preventing diseases is prepared by processing raw materials of a first main component containing first ginsenoside (selected from ginsenoside Rg1, ginsenoside Re and one of the combination thereof) and second ginsenoside (selected from ginsenoside Rb1, ginsenoside Rd and one of the combination thereof), a second main component containing glycyrrhizic acid (selected from glycyrrhizic acid, glycyrrhetinic acid and one of the combination thereof) and a third main component containing jujube cyclic adenosine monophosphate.
DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION
The invention will be further explained with reference to the drawings and the specific embodiments.
Example one
Please refer to fig. 1, which is a schematic flow chart of a method for preparing a compound nutritional health product according to an embodiment of the present invention. In figure 1, 30kg of ginseng is crushed, then is heated and extracted by 70% ethanol solution, and is separated, purified and dried by column chromatography to obtain 1.1kg of ginseng extract containing 143g of ginsenoside Rg1+ Rb 1; crushing 10kg of liquorice, heating and extracting by using 70% ethanol solution, concentrating and drying to obtain 1.9kg of liquorice extract containing 196g of glycyrrhizic acid; crushing 20kg of Chinese dates, adding water, soaking at normal temperature, filtering the soaking solution to obtain a Chinese date extract, adsorbing, separating, purifying and drying by using a macroporous resin column to obtain 66.3g of a Chinese date extract containing cAMP1.113g of the Chinese dates as a raw material for preparing the compound nutritional health-care product; then, 100g of the ginseng extract, 200g of the licorice extract and 9.2g of the Chinese date extract obtained by the method are crushed and mixed uniformly to obtain 309.2g of the compound nutritional health-care product according to the first scheme of the invention.
Example two
Please refer to fig. 2, which is a flow chart of a method for preparing a compound nutritional health product according to the second embodiment of the present invention. In the figure 2, after 120g of the ginseng extract and 2g of the jujube extract obtained in the first embodiment are added with 24g of commercially available glycyrrhetinic acid with the purity of 96 percent, and the mixture is crushed and uniformly mixed, 146g of the compound nutritional health product of the fifth embodiment of the invention is obtained.
The first experimental example: example one test for raising body temperature
1. The number of the tested persons is as follows:
16 adults, gender and age distribution are shown in Table 1.
Table 1: experimental example a sex and age distribution of the test subjects
| Age (age) | 41～50 | 51～60 | 61～70 | 71～80 | 81～90 | Total up to |
| For male | 0 | 3 | 4 | 1 | 0 | 8 |
| Woman | 2 | 2 | 1 | 1 | 2 | 8 |
2. The test mode is as follows:
the capsule prepared as the nutrition supplementary food in the first embodiment is provided for a tester to take, the average body temperature of the tester is measured before the tester takes the first embodiment, and the average body temperature of the tester is measured after the tester takes 800 mg of the first embodiment every day for 7 days.
3. And (3) test results:
the average body temperature of 13 of the testers is increased by more than 0.4 ℃, and no adverse side effect exists.
Experiment example two: EXAMPLE one Cold prevention test
1. The number of the tested persons is as follows:
6 adults, sex and age distribution are shown in Table 2.
Table 2: experimental example two sex and age distribution of the test subjects
| Age (age) | 51～60 | 61～70 | 71～80 | Total up to |
| For male | 2 | 1 | 1 | 4 |
| Woman | 2 | 0 | 0 | 2 |
2. The test mode is as follows:
the first example was prepared as a nutraceutical capsule and provided to the experimenter for administration, who took 800 mg of the first example per day for 6 consecutive months.
3. And (3) test results:
in the test process, 5 people have no cold phenomenon, 1 person has throat discomfort phenomenon for two days, and no adverse side effect exists.
The application range of the compound nutritional health product capable of increasing body temperature to prevent diseases is as follows:
1. the compound nutritional health product capable of raising body temperature to prevent diseases can contain food nutritionally and pharmaceutically acceptable additives;
2. the compound nutritional health product capable of raising body temperature to prevent diseases can be processed into various known formulations such as powder, capsules, tablets and the like; and
3. the compound nutritional health-care product capable of increasing body temperature to prevent diseases can be prepared into special medical food, health-care food, nutritional auxiliary food and medicines capable of increasing body temperature to promote metabolism and enhance immunity.
The invention is subject to various modifications as will be obvious to those skilled in the art, without however departing from the scope of the appended claims.
Claims (10)
1. A compound nutritional health product capable of raising body temperature to prevent diseases is characterized in that the compound nutritional health product comprises the following raw materials: ginseng extract, licorice extract and jujube extract.
2. The compound nutritional health product of claim 1, wherein the raw materials of the nutritional health product comprise index components of:
the ginseng extract comprises 2-27 parts by weight of ginsenoside Rg1+ Rb 1;
the licorice extract comprises 3-49 parts by weight of glycyrrhizic acid, and the glycyrrhizic acid is one selected from glycyrrhizic acid, glycyrrhetinic acid and a combination thereof; and
the jujube extract contains 0.002-0.6 weight part of jujube cyclic adenosine monophosphate.
3. The combination nutritional supplement of claim 1, wherein said combination nutritional supplement comprises a composition comprising one selected from the group consisting of a dietetic and a pharmaceutically acceptable carrier, an additive, and combinations thereof.
4. The compound nutraceutical of claim 1, wherein said compound nutraceutical is in a dosage form selected from the group consisting of a lozenge, a capsule, a powder, a tablet, a powder, a solution, a microcapsule, a suspension, an emulsion, a granule, a drop pill, a pill, and a pharmaceutical oral dosage form.
5. The compound nutraceutical of claim 1, wherein the compound nutraceutical comprises a specialized medical food, a health food, a nutritional supplement, and a pharmaceutical product that can be prepared to increase body temperature to promote metabolism and enhance immunity.
6. A compound nutritional health product capable of raising body temperature to prevent diseases, which is characterized by comprising:
the first main component: comprises 2-27 parts by weight of ginsenoside Rg1+ Rb 1;
the second main component: contains 3 to 49 parts by weight of glycyrrhizic acid, wherein the glycyrrhizic acid is one selected from glycyrrhizic acid, glycyrrhetinic acid and a combination thereof; and
the third main component: contains 0.002-0.6 weight part of jujube cyclic adenosine monophosphate.
7. The combination nutritional supplement of claim 6, wherein said combination nutritional supplement comprises a composition comprising one selected from the group consisting of a dietetic and a pharmaceutically acceptable carrier, an additive, and combinations thereof.
8. The compound nutraceutical of claim 6, wherein said compound nutraceutical is in a dosage form selected from the group consisting of a lozenge, a capsule, a powder, a tablet, a powder, a solution, a microcapsule, a suspension, an emulsion, a granule, a drop pill, a pill, and a pharmaceutical oral dosage form.
9. The compound nutraceutical of claim 6, wherein the compound nutraceutical comprises a special medical food, a health food, a nutritional supplement, and a pharmaceutical product that can be prepared to increase body temperature to promote metabolism and enhance immunity.
10. A compound nutritional health product capable of raising body temperature to prevent diseases, which is characterized by comprising:
the first main component: comprises a first ginsenoside selected from the group consisting of ginsenoside Rg1, ginsenoside Re, and combinations thereof, and a second ginsenoside selected from the group consisting of ginsenoside Rb1, ginsenoside Rd, and combinations thereof;
the second main component: comprises glycyrrhizic acid selected from glycyrrhizic acid, glycyrrhetinic acid and combinations thereof; and
the third main component: comprises annular adenosine monophosphate of Chinese date.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811108787.8A CN110934908A (en) | 2018-09-21 | 2018-09-21 | Compound nutritional health product capable of increasing body temperature to prevent diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811108787.8A CN110934908A (en) | 2018-09-21 | 2018-09-21 | Compound nutritional health product capable of increasing body temperature to prevent diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110934908A true CN110934908A (en) | 2020-03-31 |
Family
ID=69904516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811108787.8A Pending CN110934908A (en) | 2018-09-21 | 2018-09-21 | Compound nutritional health product capable of increasing body temperature to prevent diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110934908A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115300547A (en) * | 2021-05-06 | 2022-11-08 | 邢禹贤 | Application of pharmaceutical composition in preparation of medicines and health-care products for treating halitosis, hemorrhoid, leucorrhea and fishy smell and one of combination thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102138926A (en) * | 2011-01-21 | 2011-08-03 | 中山大学 | Application of ginsenoside Rd to preparing anti-depression medicament |
| CN103585169A (en) * | 2012-08-15 | 2014-02-19 | 戚郁芬 | Pharmaceutical composition capable of increasing the content and the utilization degree of cyclic adenosine monophosphate in vivo and manufacturing method of the pharmaceutical composition |
-
2018
- 2018-09-21 CN CN201811108787.8A patent/CN110934908A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102138926A (en) * | 2011-01-21 | 2011-08-03 | 中山大学 | Application of ginsenoside Rd to preparing anti-depression medicament |
| CN103585169A (en) * | 2012-08-15 | 2014-02-19 | 戚郁芬 | Pharmaceutical composition capable of increasing the content and the utilization degree of cyclic adenosine monophosphate in vivo and manufacturing method of the pharmaceutical composition |
Non-Patent Citations (2)
| Title |
|---|
| 安欣: "《健康美人36.7℃》", 28 February 2010, 蓝天出版社 * |
| 杨雄志: "三叶青提取物解热作用及对大白鼠下丘脑5-羟色胺、去甲肾上腺素、多巴胺含量的影响", 《长春中医药大学学报》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115300547A (en) * | 2021-05-06 | 2022-11-08 | 邢禹贤 | Application of pharmaceutical composition in preparation of medicines and health-care products for treating halitosis, hemorrhoid, leucorrhea and fishy smell and one of combination thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107126485B (en) | Traditional Chinese medicine composition for assisting in improving sleep and preparation method and application thereof | |
| CN102764340A (en) | Traditional Chinese medicine composite capable of improving sleep and preparation method and application thereof | |
| WO2013071727A1 (en) | Anti-tumor traditional chinese medical composition | |
| CN104173493A (en) | Pharmaceutical composition with effect of improving sleep as well as preparation method and application of pharmaceutical composition | |
| CN103355655A (en) | Composition with alimentary anemia improving function and preparation method of composition | |
| CN113115940A (en) | Heart calming and sleep aiding composition as well as preparation method and application thereof | |
| CN103611075A (en) | Bezoar refreshing preparation and preparation method thereof | |
| CN102697825B (en) | Anti-aging health-care product | |
| CN110934908A (en) | Compound nutritional health product capable of increasing body temperature to prevent diseases | |
| CN102885346A (en) | Wheat, jujube and rose beverage for nourishing heart and soothing nerves and preparation method thereof | |
| US20230125425A1 (en) | Traditional chinese medicine extract composition with function of regulating depressive emotion and preparation method and traditional chinese medicine preparation thereof | |
| CN105456689A (en) | Traditional Chinese medicine composition for treating diabetes as well as preparation method and application of traditional Chinese medicine composition | |
| CN101810679A (en) | Polyunsaturated fatty acid soft capsule and preparation method thereof | |
| CN111298020B (en) | Traditional Chinese medicine composition with anti-fatigue effect and preparation method and application thereof | |
| KR20180126231A (en) | A composition comprising herbal mixture extract for neuroprotection | |
| CN102908396A (en) | Chinese medicinal composition for promoting sleeping and preparation method thereof | |
| CN108904596B (en) | Composition with memory improving effect | |
| CN111194913A (en) | Composition for improving sleep, preparation method and application thereof | |
| TW202011832A (en) | Compound nutrition and health-care product capable of rising body temperature to prevent disease which is manufactured by using main components including ginseng extract, licorice extract and jujube extract | |
| CN104383449B (en) | Pharmaceutical composition for treating depression syndrome | |
| CN117018095B (en) | Pharmaceutical composition for treating autism and application thereof | |
| CN107137656A (en) | A kind of Chinese medicine composition for treating pregnant depression | |
| TWI793922B (en) | Composition for enhancing cognitive abilities and use thereof | |
| CN112791166B (en) | Medicinal and edible composition for enhancing muscle performance and relieving exercise-induced fatigue | |
| CN102327304A (en) | Drug for preventing and controlling chronic mountain sickness and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200331 |